| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $103.8M | — | -44.7% |
| SG&A Expense | $26.6M | — | -21.7% |
| Operating Income | -$130.4M | — | +41.1% |
| Pre-tax Income | -$130.3M | — | +41.1% |
| Income Tax | $272K | — | -55.3% |
| Net Income | -$130.5M | — | +41.1% |
| EPS (Basic) | -$0.88 | — | +59.4% |
| EPS (Diluted) | -$0.88 | — | +59.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $273.1M | +18.8% | +177.5% |
| Short-term Investments | $74.7M | -16.2% | -66.7% |
| Current Assets | $385.6M | +4.7% | +0.8% |
| Total Assets | $466.4M | +3.3% | +1.6% |
| Current Liabilities | $52.1M | -55.1% | -68.3% |
| Total Liabilities | $336.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$149.9M | — | +9.2% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $15.2M | — | -90.8% |
| Financing Cash Flow | $179.0M | — | — |
| Free Cash Flow | -$149.9M | — | +9.5% |
| +68.9% |
| Stockholders' Equity | $129.5M | +148.7% | -50.1% |